EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Kidney Disease in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review

Matthew M Poppe, An Tai, X Allen Li, Moyed Miften, Arthur Olch, Lawrence B Marks, Bilal Mazhar Qureshi, Sheri L Spunt, Margarett Shnorhavorian, Geoff Nelson, Cecile Ronckers, John Kalapurakal und 3 weitere

International Journal of Radiation Oncology*Biology*Physics · 2024

DOI: 10.1016/j.ijrobp.2023.02.040 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2024. Verfasst von Matthew M Poppe und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah. Electronic address: Matthew.Poppe@hci.utah.edu. Hauptthemen laut MEDLINE: Cancer Survivors, Kidney Diseases, Radiation Injuries. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 87 Literaturangaben. Gefördert von: American Association of Physicists in Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Kidney injury is a known late and potentially devastating complication of abdominal radiation therapy (RT) in pediatric patients. A comprehensive Pediatric Normal Tissue Effects in the Clinic review by the Genitourinary (GU) Task Force aimed to describe RT dose-volume relationships for GU dysfunction, including kidney, bladder, and hypertension, for pediatric malignancies. The effect of chemotherapy was also considered. METHODS AND MATERIALS: We conducted a comprehensive PubMed search of peer-reviewed manuscripts published from 1990 to 2017 for investigations on RT-associated GU toxicities in children treated for cancer. We retrieved 3271 articles with 100 fulfilling criteria for full review, 24 with RT dose data and 13 adequate for modeling. Endpoints were heterogenous and grouped according to National Kidney Foundation: grade ≥1, grade ≥2, and grade ≥3. We modeled whole kidney exposure from total body irradiation (TBI) for hematopoietic stem cell transplant and whole abdominal irradiation (WAI) for patients with Wilms tumor. Partial kidney tolerance was modeled from a single publication from 2021 after the comprehensive review revealed no usable partial kidney data. Inadequate data existed for analysis of bladder RT-associated toxicities. RESULTS: The 13 reports with long-term GU outcomes suitable for modeling included 4 on WAI for Wilms tumor, 8 on TBI, and 1 for partial renal RT exposure. These reports evaluated a total of 1191 pediatric patients, including: WAI 86, TBI 666, and 439 partial kidney. The age range at the time of RT was 1 month to 18 years with medians of 2 to 11 years in the various reports. In our whole kidney analysis we were unable to include chemotherapy because of the heterogeneity of regimens and paucity of data. Age-specific toxicity data were also unavailable. Wilms studies occurred from 1968 to 2011 with mean follow-ups 8 to 15 years. TBI studies occurred from 1969 to 2004 with mean follow-ups of 4 months to 16 years. We modeled risk of dysfunction by RT dose and grade of toxicity. Normal tissue complication rates ≥5%, expressed as equivalent doses, 2 Gy/fx for whole kidney exposures occurred at 8.5, 10.2, and 14.5 Gy for National Kidney Foundation grades ≥1, ≥2, and ≥3, respectively. Conventional Wilms WAI of 10.5 Gy in 6 fx had risks of ≥grade 2 toxicity 4% and ≥grade 3 toxicity 1%. For fractionated 12 Gy TBI, those risks were 8% and

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer SurvivorsKidney DiseasesRadiation InjuriesAdolescentChildChild, PreschoolHumansInfantHematopoietic Stem Cell TransplantationHypertensionKidneyKidney NeoplasmsNeoplasmsOrgans at RiskRadiotherapy DosageUrinary BladderWhole-Body IrradiationWilms TumorInfant, Newborn

Autor:innen und Institutionen

  • Department of Radiation Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah. Electronic address: Matthew.Poppe@hci.utah.edu.
  • Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Department of Radiation Oncology, University of Colorado School of Medicine, Denver, Colorado.
  • Department of Radiation Oncology, Keck School of Medicine, University of Southern California, and Children's Hospital Los Angeles, Los Angeles, California.
  • Department of Radiation Oncology, University of North Carolina, Chapel Hill, North Carolina.
  • Radiation Oncology Section, Department of Oncology, Aga Khan University, Karachi, Pakistan.

Förderung

  • American Association of Physicists in Medicine

Zitieren

APA

Poppe, M. M., Tai, A., Li, X. A., Miften, M., Olch, A., Marks, L. B., Qureshi, B. M., Spunt, S. L., Shnorhavorian, M., Nelson, G., Ronckers, C., Kalapurakal, J., Marples, B., Constine, L. S., & Liu, A. K. (2024). Kidney Disease in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2023.02.040

Vancouver

Poppe MM, Tai A, Li XA, Miften M, Olch A, Marks LB, et al. Kidney Disease in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review. International Journal of Radiation Oncology*Biology*Physics. 2024. doi:10.1016/j.ijrobp.2023.02.040

BibTeX
@article{Poppe2024,
  author = {Poppe, Matthew M and Tai, An and Li, X Allen and Miften, Moyed and Olch, Arthur and Marks, Lawrence B and Qureshi, Bilal Mazhar and Spunt, Sheri L and Shnorhavorian, Margarett and Nelson, Geoff and Ronckers, Cecile and Kalapurakal, John and Marples, Brian and Constine, Louis S and Liu, Arthur K},
  title = {Kidney Disease in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2024},
  doi = {10.1016/j.ijrobp.2023.02.040}
}
Kostenlos starten →